mTOR in podocyte function: Is rapamycin good for diabetic nephropathy?

Cell Cycle

Volumn 10, Issue 20, 2011, Pages 3415-3416

  Lu, Min Kan ^a   Gong, Xing Guo ^a   Guan, Kun Liang ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b San Diego   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; NEPHRIN; PROTEIN; RAPAMYCIN; RAPTOR PROTEIN; RICTOR PROTEIN; UNCLASSIFIED DRUG;

CELL FUNCTION; DIABETIC NEPHROPATHY; EDITORIAL; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIUM CELL; GLOMERULOSCLEROSIS; HUMAN; KIDNEY FAILURE; NONHUMAN; PODOCYTE; PROTEIN LOCALIZATION;

EID: 80055108638     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.20.17686     Document Type: Editorial

References (5)

1. Rossing P, et al. Kidney Int 2011; 79:28-32.
2. Pavenstädt H, et al. Physiol Rev 2003; 83:253-307.
3. Inoki K, et al. J Clin Invest 2011; 121:2181-96.
4. Gödel M, et al. J Clin Invest 2011; 121:2197-209.
5. Zoncu R, et al. Nat Rev Mol Cell Biol 2011; 12:21-35.